• home
  • the advantage
  • about us
    • key facts
    • where we are
    • where we invest
    • management team
    • funds
  • investments
    • focus
      • prevention & nutraceuticals
      • medical foods OTC, Rx
      • enabling technologies
      • brands & channels
      • diagnostics
    • CEOs
    • portfolio
    • criteria
    • process
  • news
  • your business
  • careers
  • contact us
    • the bahamas
    • united kingdom
    • switzerland
    • new zealand

about us

where we invest

  • We invest worldwide
  • We invest in
    • Life-sciences and biotechnology
    • Drugs, OTC and medical foods
    • Enabling technologies and services
    • Health and wellness brands
    • Diagnostics
    • Functional foods, nutraceuticals and dietary supplements
    • See our investment focus for more info
  • We invest in all stages of company development
  • Between $10 million to $15 million is a normal investment size
  • We deliver the inventages advantage as an active and involved investor
Stephen Appelbee, CM&D Pharma
Stephen Appelbee, CM&D Pharma:
"Inventages were there at a crucial stage in our Company's growth, when we needed to acquire our first major assets." More...
Terms Print Top
© 2012 Inventages